Neurocentria
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
200 Pringle Ave, Walnut Creek, Californi...Phone Number
(925) 954-4868Website
www.neurocentria.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Neurocentria
Neurocentria Inc. is dedicated to developing innovative therapies for individuals with neuropsychiatric and neurodegenerative disorders. The company focuses on a unique mechanism of action that enhances synaptic function and promotes synaptogenesis through a proprietary compound that elevates intracellular magnesium levels. Their clinical programs include trials for ADHD, depression, and Alzheimer's disease, alongside a nutraceutical aimed at improving brain health for healthy individuals. With a patient-focused and science-backed approach, Neurocentria aims to provide life-changing treatment options.Explore more
Neurocentria Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neurocentria your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Neurocentria, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Neurocentria recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Neurocentria
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Neurocentria has new funding data
Check out if Neurocentria is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Neurocentria had a recent Job posting/layoffs
Check if Neurocentria has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Neurocentria launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Neurocentria
Compare insights from companies similar to Neurocentria, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Neurocentria is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neurocentria is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neurocentria.
Neurocentria financials insights
Gather financial insights about Neurocentria, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Neurocentria Tech Stack
A closer look at the technologies used by Neurocentria
Neurocentria News & Media
Neurocentria Obtains FDA Approval to Conduct Pivotal Phase IIb/III Clinical Trial for Testing Safety and Efficacy of Drug Candidate NRCT-101SR in Adults With ADHD
Novel NRCT-101SR shown in previous human studies to be effective and well-tolerated with no side effects
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neurocentria
Sign Up For FreeTo access detailed company insights
Neurocentria Inc. is dedicated to developing innovative therapies for individuals with neuropsychiatric and neurodegenerative disorders. The company focuses on a unique mechanism of action that enhances synaptic function and promotes synaptogenesis through a proprietary compound that elevates intracellular magnesium levels. Their clinical programs... Read More
